SOPH

Dopo l'orario di chiusura: 8.50 0.05 +0.59%

Sophia Genetics Sa (SOPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1033)

Prossima data di guadagno

Ultimi documenti SEC

SOPH's Discussions on Twitter

Compare SOPH vs VEEV, TEM, BTSG, HQY, TXG

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SOPH Sophia Genetics Sa	8.45	709.11M	81.18M	-80.94M	-55.15M	-1.1809
VEEV Veeva Systems Inc	248.46	40.70B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	66.17	12.03B	1.36B	-302.91M	-219.93M	-1.7182
BTSG Brightspring Health Services Inc	59.49	11.78B	13.65B	169.86M	412.12M	1.0758
HQY Healthequity Inc	105.40	8.72B	1.34B	230.70M	440.96M	2.6695
TXG 10 X Genomics Inc	63.80	8.32B	638.78M	-22.66M	122.18M	-0.1744

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-18	Iniziato	Craig Hallum	Buy
2024-08-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Iniziato	Guggenheim	Buy
2023-11-29	Iniziato	RBC Capital Mkts	Outperform
2023-07-05	Ripresa	JP Morgan	Overweight
2023-01-03	Iniziato	BTIG Research	Buy
2022-11-23	Iniziato	Credit Suisse	Neutral
2021-10-15	Ripresa	Cowen	Outperform
2021-08-17	Iniziato	Cowen	Outperform
2021-08-17	Iniziato	Credit Suisse	Outperform
2021-08-17	Iniziato	JP Morgan	Overweight
2021-08-17	Iniziato	Morgan Stanley	Overweight

Mostra tutto

Sophia Genetics Sa Borsa (SOPH) Ultime notizie

Sophia Genetics Sa Azioni (SOPH) Dati Finanziari

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Compare SOPH vs VEEV, TEM, BTSG, HQY, TXG

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Borsa (SOPH) Ultime notizie

SOPHiA GENETICS Chief Scientific Officer Xu Zhenyu Sells 20,000 Shares Over Three Days - Kalkine Media

SOPHiA GENETICS (NASDAQ: SOPH) officer may sell founder shares - Stock Titan

SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale - Stock Titan

SOPHiA GENETICS (NASDAQ: SOPH) officer plans additional 8,000-share sale - Stock Titan

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month HighShould You Buy? - MarketBeat

EBIT per share of SOPHiA GENETICS SA – DUS:90B - TradingView

SOPHiA GENETICS SA (NASDAQ:SOPH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

SOPHiA Genetics Earnings Call Highlights Growth Push - TipRanks

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript - AOL.com

Sophia Genetics SA (SOPH) Chief Scientific Officer Zhenyu Xu Sel - GuruFocus

SOPHiA GENETICS (SOPH) Slips 1.57% as Shares Consolidate Between Key Support and ResistanceStock Surge Alerts - vinanet.vn

SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares - MarketBeat

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 4,000 Shares of Stock - MarketBeat

SOPHiA GENETICS (SOPH) Slips 0.53% to $7.57 as Genomics AI Stock Consolidates Between Key LevelsSeasonality Effect - Vinanet

SOPHiA GENETICS (SOPH) Consolidates at $7.57: Genomics Stock Poised Between Support and ResistanceCorrective Wave - vinanet.vn

Sophia Genetics (SOPH) Executive Chairman Jurgi Camblong Sells 2 - GuruFocus

SOPHiA GENETICS (NASDAQ:SOPH) Reaches New 52-Week HighTime to Buy? - MarketBeat

Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

Abhimanyu Verma Sells 5,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells 20,000 Shares - MarketBeat

Sei Investments Co. Buys Shares of 357,888 SOPHiA GENETICS SA $SOPH - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $123,930.00 in Stock - MarketBeat

SOPH (NASDAQ: SOPH) insider schedules 22,000-share sale under 10b5-1 plan - Stock Titan

SOPHiA GENETICS (SOPH) insider plans Rule 144 sale after 10b5-1 trades - Stock Titan

Sophia Genetics CSO Zhenyu Xu disposes of USD 170,872 in common shares - Bitget

SOPHiA GENETICS Q3 EPS Estimate Lowered by HC Wainwright - MarketBeat

Three Swiss biotechs widen their reach into pharma, paediatrics and lung disease - Startupticker.ch

HC Wainwright Predicts Reduced Earnings for SOPHiA GENETICS - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 10,000 Shares - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $138,400.00 in Stock - MarketBeat

BTIG raises Sophia Genetics stock price target on CDx deals By Investing.com - Investing.com South Africa

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade - MarketBeat

SOPH Stock Price and Chart — NASDAQ:SOPH - tradingview.com

BTIG Research Issues Positive Forecast for SOPHiA GENETICS (NASDAQ:SOPH) Stock Price - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat

SOPHiA GENETICS Updates Investors With Q2 2026 Form 6-K Filing - The Globe and Mail

BTIG raises Sophia Genetics stock price target on CDx deals - Investing.com

SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics - Yahoo Finance

SOPHiA GENETICS (NASDAQ:SOPH) Shares Up 10.5%Here's Why - MarketBeat

Jurgi Camblong (SOPH) plans 20,000-share sale and details 10b5-1 trades - Stock Titan

SOPHiA GENETICS (SOPH) insider Zhenyu Xu plans 10,000-share stock sale - Stock Titan

Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ... - Yahoo! Finance Canada

SOPHiA GENETICS Q2 Earnings Call Highlights - MarketBeat

Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies - marketscreener.com

SOPH: Q2 revenue up 27% year-over-year, guidance raised, and major biopharma wins secured - TradingView

Earnings call transcript: SOPHiA GENETICS tops revenue estimates in Q2 2026 - Investing.com

SOPH Looks 11.8% Overvalued on GF Value™ - GuruFocus

SOPHiA GENETICS (NASDAQ:SOPH) Issues Quarterly Earnings Results - MarketBeat

Sophia Genetics SA reports results for the quarter ended June 30Earnings Summary - TradingView

SOPH: Q2 2026 revenue rose 27% YoY, with strong U.S. and Liquid Biopsy growth and improved EBITDA loss - TradingView

[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) - Stock Titan

Sophia Genetics Sa Azioni (SOPH) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SOPH